Steven K. Barg's most recent trade in Charles River Laboratories International Inc. was a trade of 2,082 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Laboratories... | Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 2,082 | 2,082 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 135.04 per share. | 02 Jun 2025 | 946 | 1,427 (0%) | 0% | 135.0 | 127,748 | Common Stock |
| Charles River Laboratories... | Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 135.04 per share. | 02 Jun 2025 | 481 | 481 (0%) | 0% | 135.0 | 64,954 | Common Stock |
| Catalent Inc. | Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2024 | 4,663 | 12,374 (0%) | 0% | 0 | Common Stock | |
| Cardinal Health, Inc. | Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 1,965 | 4,739 (0%) | 0% | 0 | Common Shares | |
| Catalent Inc. | Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2023 | 6,993 | 7,711 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Steven K. Barg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2023 | 718 | 718 (0%) | 0% | 0 | Common Stock |